Elsevier secures publishing rights for premium titles for 2023

Elsevier, a leading scientific publisher, and global information analytics business specializing in science and health, announced today that it will be the new publisher of six influential society journals starting in January 2023:

• American Journal of Clinical Nutrition

• The Journal of Nutrition

• Journal of Thrombosis and Haemostasis

• American Journal of Transplantation

• Laboratory Investigation

• Modern Pathology

The newly acquired titles represent the following societies and add to Elsevier’s expansive global health publishing portfolio:

• American Society for Nutrition (ASN)

• United States and Canadian Academy of Pathology (USCAP)

• International Society on Thrombosis and Haemostasis (ISTH)

• The American Society of Transplant Surgeons (ASTS)

• American Society of Transplantation (AST)

All are considered internationally renowned sources of knowledge and impactful study in the fields of pathology, nutrition, transplantation, haematology and peripheral vascular disease.

“It is an honor to partner with five established societies that have trusted Elsevier as the official publisher of their important journals. True to our commitment to supporting research and clinical practice, we are dedicated to placing our full range of industry-leading resources for authors, editors, reviewers and readers, in the disposal of our latest additions. With our continuous support and seamless collaboration these six valued titles can harness the benefits of a reliable global publishing partner allowing them to maximize their contribution to scientific research and clinical practice in their respective fields” said Carl Schwarz Senior Vice President, Health and Medical Sciences, at Elsevier. Elsevier will officially welcome the journals into their portfolio beginning in January 2023. They will be part of Elsevier’s title-by-title subscription model instead of a collection.

Learn more about these exceptional titles or contact us for more information.

Acerca de Elsevier

Elsevier es líder global en información avanzada y soporte para la toma de decisiones. Durante más de un siglo, ha ayudado a avanzar la ciencia y la salud para promover el progreso humano. Apoya a comunidades de investigación académicas y corporativas, médicos, enfermeras, futuros profesionales de la salud y educadores en 170 países, proporcionándoles conocimientos críticos y soluciones innovadoras que combinan contenido científico y médico confiable con tecnologías de IA de vanguardia. Elsevier promueve la inclusión y la sostenibilidad incorporando estos valores en sus productos y cultura. La Elsevier Foundation respalda investigaciones y asociaciones de salud alrededor del mundo.

Elsevier forma parte de RELX, proveedor global de herramientas de análisis y decisión basadas en información para clientes profesionales y de negocios. Para más información, visite www.elsevier.com y síganos en redes sociales: @ElsevierConnect.